Page last updated: 2024-08-24

nelfinavir and Hyperlipemia

nelfinavir has been researched along with Hyperlipemia in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (23.08)	18.2507
2000's	10 (76.92)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukushima, K; Haraya, K; Maeda, Y; Sugioka, N; Takada, K	1
Cahn, P; Giordano, M; Kelleher, T; Mancini, M; Murphy, R; Pantaleo, G; Phanuphak, P; Pokrovskiy, V; Rozenbaum, W; Sension, M; Wood, R	1
Coupal, L; Gilmore, N; Grover, SA; Mukherjee, J	1
Averitt, D; Kumar, PN; Pakes, GE; Pappa, KA; Rodriguez-French, A; Shaefer, MS; Tashima, KT; Thompson, MA; Wannamaker, PG; Williams, VC	1
Coleman, CI; White, CM	1
Burton, S; Carr, A; Chisholm, DJ; Cooper, DA; Freund, J; Law, M; Samaras, K	1
Carver, PL; Cinti, SK; Kaul, DR; Kazanjian, PH	1
Cheseaux, JJ; Darioli, R; Glauser, MP; Halfon, P; Marcovina, SM; Mooser, V; Nicod, P; Périard, D; Reymond, MJ; Sudre, P; Telenti, A	1
Duncombe, C	1
Decker, CF; Martin, GJ; Smith, JH	1
Ammassari, A; Baldini, F; Cingolani, A; De Luca, A; Di Giambenedetto, S; Murri, R	1
Croom, DK; Lenhard, JM; Weiel, JE; Winegar, DA	1
Beall, GN; Chang, ES; Liu, YT; Tetreault, DD	1

Reviews

1 review(s) available for nelfinavir and Hyperlipemia

Article	Year
HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications. Pharmacotherapy, 1999, Volume: 19, Issue:3 Topics: Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Indinavir; Lipodystrophy; Nelfinavir; Ritonavir; Saquinavir	1999

Trials

4 trial(s) available for nelfinavir and Hyperlipemia

Article	Year
Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir. Journal of acquired immune deficiency syndromes (1999), 2004, Jun-01, Volume: 36, Issue:2 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Cholesterol, LDL; Female; HIV Infections; Humans; Hyperlipidemias; Lamivudine; Lipids; Male; Nelfinavir; Oligopeptides; Pyridines; RNA, Viral; Safety; Stavudine; Time Factors; Triglycerides	2004
Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy. The American journal of cardiology, 2005, Mar-01, Volume: 95, Issue:5 Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardiovascular Diseases; Female; HIV Infections; Humans; Hyperlipidemias; Lamivudine; Life Expectancy; Male; Markov Chains; Middle Aged; Nelfinavir; Oligopeptides; Pyridines; Risk Factors; Stavudine	2005
A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity. HIV medicine, 2006, Volume: 7, Issue:2 Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Female; Hispanic or Latino; HIV Infections; HIV-1; Humans; Hyperlipidemias; Lactic Acid; Lamivudine; Male; Nelfinavir; Nevirapine; Prospective Studies; Sex Factors; Stavudine; Treatment Outcome; Triglycerides; Zidovudine	2006
Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study. AIDS (London, England), 2000, Jul-28, Volume: 14, Issue:11 Topics: Adult; Anticholesteremic Agents; Drug Tolerance; Female; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hyperlipidemias; Indinavir; Male; Nelfinavir; Pilot Projects; Pravastatin; Ritonavir; Saquinavir; Treatment Outcome	2000

Other Studies

8 other study(ies) available for nelfinavir and Hyperlipemia

Article	Year
Pharmacokinetics of human immunodeficiency virus protease inhibitor, nelfinavir, in poloxamer 407-induced hyperlipidemic model rats. Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:2 Topics: Algorithms; Animals; Area Under Curve; Blotting, Western; Cholesterol; Half-Life; HIV Protease Inhibitors; Hyperlipidemias; Injections, Intravenous; Lipids; Lipoproteins; Male; Mass Spectrometry; Nelfinavir; Poloxamer; Protein Binding; Rats; Rats, Wistar	2009
A comparison of different protease inhibitors on coronary heart disease risk. Connecticut medicine, 2007, Volume: 71, Issue:1 Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Clinical Trials as Topic; Coronary Disease; HIV Protease Inhibitors; HIV Seropositivity; Humans; Hyperlipidemias; Nelfinavir; Oligopeptides; Pyridines; Risk Factors	2007
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS (London, England), 1998, May-07, Volume: 12, Issue:7 Topics: Adult; Anti-HIV Agents; Body Composition; Cross-Sectional Studies; Diabetes Mellitus; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Indinavir; Insulin Resistance; Lipodystrophy; Male; Nelfinavir; Risk Factors; Ritonavir; Saquinavir; Syndrome	1998
Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation, 1999, Aug-17, Volume: 100, Issue:7 Topics: Adult; Anti-HIV Agents; Arteriosclerosis; Child; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Indinavir; Lipids; Lipoprotein(a); Lipoproteins; Logistic Models; Male; Nelfinavir; Risk Factors; Ritonavir; Saquinavir; Thyrotropin	1999
Reversal of hyperlipidemia and lipodystrophy in patients switching therapy to nelfinavir. Journal of acquired immune deficiency syndromes (1999), 2000, May-01, Volume: 24, Issue:1 Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lipodystrophy; Nelfinavir; Prospective Studies	2000
Hyperlipidemia associated with the use of protease inhibitors. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:1 Topics: Adult; Anti-HIV Agents; Cholesterol; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Indinavir; Male; Nelfinavir; Ritonavir; Saquinavir; Triglycerides	2000
HIV protease inhibitors stimulate hepatic triglyceride synthesis. Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:12 Topics: Acyltransferases; Animals; Blood Glucose; Carbon Radioisotopes; Cholesterol; Diacylglycerol O-Acyltransferase; Fasting; Fatty Acid Synthases; Fatty Acids; HIV Protease Inhibitors; Hyperlipidemias; Liver; Male; Mice; Mice, Inbred AKR; Nelfinavir; Nicotinic Acids; Postprandial Period; Receptors, Retinoic Acid; Retinoid X Receptors; Ritonavir; RNA, Messenger; Saquinavir; Tetrahydronaphthalenes; Transcription Factors; Triglycerides; Tumor Cells, Cultured	2000
The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients. Journal of the American Dietetic Association, 2001, Volume: 101, Issue:6 Topics: Adipose Tissue; Adult; Aged; Cholesterol; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Indinavir; Male; Middle Aged; Nelfinavir; Retrospective Studies; Ritonavir; Saquinavir; Triglycerides	2001